TCIRG1 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with TCIRG1 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with TCIRG1 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with TCIRG1 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TCIRG1 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000086967 - myosin binding protein C2

Gene

ENSG00000178585 - catenin beta interacting protein 1

Gene

ENSG00000162551 - alkaline phosphatase, biomineralization associated

Gene

ENSG00000112339 - HBS1 like translational GTPase

Gene

ENSG00000068976 - glycogen phosphorylase, muscle associated

Gene

ENSG00000114805 - phospholipase C eta 1

Gene

ENSG00000118729 - calsequestrin 2

Gene

ENSG00000177791 - myozenin 1

Gene

ENSG00000105131 - epoxide hydrolase 3

  • Gene

    ENSG00000086967 - myosin binding protein C2


  • Gene

    ENSG00000178585 - catenin beta interacting protein 1


  • Gene

    ENSG00000162551 - alkaline phosphatase, biomineralization associated


  • Gene

    ENSG00000112339 - HBS1 like translational GTPase


  • Gene

    ENSG00000068976 - glycogen phosphorylase, muscle associated


  • Gene

    ENSG00000114805 - phospholipase C eta 1


  • Gene

    ENSG00000118729 - calsequestrin 2


  • Gene

    ENSG00000177791 - myozenin 1


  • Gene

    ENSG00000105131 - epoxide hydrolase 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.